ライフサイエンスコーパス: reliever

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 ent a promising new generation of novel pain relievers.

2 ally acceptable for an over-the-counter pain reliever?

3 Decreases in use were smaller for pain relievers and antidepressants and larger for acid suppre

4 nt the largest and most potent class of pain relievers available to treat both acute and chronic pain

5 orly adherent patients who overrely on their reliever beta-agonist inhaler.

6 Morphine is a powerful pain reliever, but also a potent inducer of tolerance and dep

7 en admitted to hospitals with asthma receive relievers (CAC-1) and systemic corticosteroids (CAC-2) a

8 , a vasodilator, anti-inflammatory, and pain reliever, could alter the pathophysiology of sickle cell

9 he chronic usefulness of this excellent pain reliever in man.

10 indomethacin, the drugs widely used as pain relievers in the clinic, can surmount axon growth restri

11 in FEV1, symptoms, and use of supplementary reliever medication.

12 edication dispensations, and dispensation of reliever medications.

13 elief (sometimes referred to as "rescue" or "reliever") medications.

14 vitamin D-deficient mice with the ER stress reliever PBA during HF feeding suppressed atherosclerosi

15 or ICS/long-acting beta-agonist inhaler as a reliever rather than regular maintenance use.

16 aled steroids, the Symbicort maintenance and reliever (SMART) regimen (with budesonide and formoterol

17 with a fixed-dose regimen with salbutamol as reliever ('Standard'), actual medication use was measure

18 Thus, vitamin D is a natural ER stress reliever that induced an antiatherogenic monocyte/macrop

19 udesonide-formoterol inhaler Maintenance And Reliever Therapy (SMART) regimen reduces severe asthma e

20 costeroid and long-acting beta(2)-agonist as reliever therapy in addition to maintenance treatment.

21 ayers medicated for asthma/EIB (a third with reliever therapy only) do not present reversible airway

22 paring budesonide/formoterol maintenance and reliever therapy with fixed-dose inhaled corticosteroid/

23 o budesonide plus formoterol maintenance and reliever therapy, fixed-dose budesonide plus formoterol,

24 ry events based on peak expiratory flow (P), reliever use (R), symptoms (S), awakenings (A), and thre

25 0.74, 95% CI 0.72-0.77), defined as limited reliever use and no asthma-related hospital attendance o

26 On multivariate analysis, GINA step, reliever use, postbronchodilator FEV1, and 5-item Asthma

27 Main outcomes were controller use, reliever use, unscheduled doctor visits, emergency depar

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。